RESUMO
PURPOSE OF INVESTIGATION: To assess the preliminary results of tubal surgery and its effect on pregnancy outcome. MATERIALS AND METHODS: The study included 440 patients with unilateral or bilateral tubal disease as the only cause of the infertility. All patients undergoing a laparoscopy for infertility were studied in reproductive surgery centre. The fallopian tube was classified into class I-IV. The studied outcomes were live birth, ectopic pregnancy, and miscarriage. After 12 months, cumulative conception rate was calculated. RESULTS: In the 440 patients, 172 patients with mild salpinx abnormality (class I) had a 34% cumulative pregnancy rate, 151 patients with moderate salpinx abnormality (class II) had a 16% cumulative pregnancy rate, and 77 patients with severe salpinx abnormality (class III) had a 10% cumulative pregnancy rate. No intrauterine pregnancies were observed in the severe group of 40 patients (class IV). CONCLUSION: Surgical laparoscopy is helpful for class I and II tubal abnormality, while it is not for class III and IV abnormalities.
Assuntos
Doenças das Tubas Uterinas/cirurgia , Infertilidade Feminina/cirurgia , Aborto Espontâneo , Adulto , China , Doenças das Tubas Uterinas/patologia , Feminino , Humanos , Laparoscopia/métodos , Gravidez , Resultado da Gravidez , Gravidez Ectópica , Índice de Gravidade de DoençaRESUMO
Chromatin assembly factor-1 (CAF-1) plays essential roles in eukaryotic chromatin assembly during DNA replication (Smith and Stillman, 1989. Cell 58, 15-25), (Krude, 1999. Eur. J. Biochem. 263, 1-5). Its p150 subunit, involved in interaction with histone H3 and H4, is critical to the CAF-1 nucleosome assembly activity. In this study, we sequenced a 96-kb genomic DNA region that includes a 42.8-kb CAF-1 p150 subunit gene (CHAF1A), and a 41.1-kb EEN gene. A scripted bioinformatics analysis pipeline (research agent) has been set up to annotate the BAC sequence with a set of integrated algorithms. The CAF-1 p150 subunit gene contains 15 exons and 14 introns. The promoter region is characterized by deletional analyses, revealing a potential repressor. Tissue-correlated alternative splicing forms of the transcript was initially identified by EST clustering analysis, then confirmed by RT-PCR which resulted more splicing forms than computational prediction.
Assuntos
Proteínas Cromossômicas não Histona , Proteínas de Ligação a DNA/genética , Genes/genética , Células 3T3 , Processamento Alternativo , Sequência de Aminoácidos , Animais , Sequência de Bases , Células COS , Fator 1 de Modelagem da Cromatina , Biologia Computacional , DNA/química , DNA/genética , DNA Complementar/genética , Humanos , Luciferases/genética , Luciferases/metabolismo , Camundongos , Dados de Sequência Molecular , Regiões Promotoras Genéticas/genética , Subunidades Proteicas , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Alinhamento de Sequência , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos , Fatores de TranscriçãoRESUMO
INTRODUCTION: To study the relationship between the expression level of the PML-RARalpha fusion transcripts and the clinical status and efficiency of the therapy in acute promyelocytic leukemia (APL) patients, we applied a very sensitive and specific real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR) system to quantify the dose of PML-RARalpha fusion transcripts in a series of APL patients at distinct disease stages. MATERIALS AND METHODS: A total of 31 APL patients (19 males and 12 females; aged from 8 to 74 years) from eight hospitals in Shanghai were analysed. Real-time Quantitative RT-PCR was used to measure the normalized dose (DoseN) of PML-RARalpha fusion transcripts. RESULTS: A wide range of PML-RARalpha DoseN above 1 x 10(3) was noted in 25 newly diagnosed patients. PML-RARalpha DoseN was significantly decreased after remission induction with ATRA, ATRA/chemotherapy or As2O3 and further reduced after consolidation. The fact that all patients with long disease free survival had a constantly low PML-RARalpha DoseN below 2 x 10(2) and a higher level predicted impending relapse suggests that this value could serve as a 'threshold' for molecular remission. PML-RARalpha DoseN was also of prognostic value in a group of relapsed patients, since good response to As2O3 reinduction was accompanied by a remarkable reduction of fusion transcript level, whereas patients with high PML-RARalpha Dose(N) after the second CR tended to relapse again rapidly. CONCLUSION: These results confirm that real-time RT-PCR assay for PML-RARalpha transcripts in APL patients is useful in reflecting leukemic burden, assessing response to treatment and indicating the ultimate clinical outcome or curability of disease.
Assuntos
Leucemia Promielocítica Aguda/diagnóstico , Proteínas de Neoplasias/análise , Proteínas de Fusão Oncogênica/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa/normas , Adolescente , Adulto , Idoso , Antineoplásicos/administração & dosagem , Medula Óssea/patologia , Criança , Progressão da Doença , Intervalo Livre de Doença , Estudos de Viabilidade , Feminino , Humanos , Leucemia Promielocítica Aguda/tratamento farmacológico , Leucemia Promielocítica Aguda/genética , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias/genética , Neoplasia Residual/diagnóstico , Neoplasia Residual/genética , Proteínas de Fusão Oncogênica/genética , Prognóstico , RNA Mensageiro/análise , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
The primary neuroendocrine interface, hypothalamus and pituitary, together with adrenals, constitute the major axis responsible for the maintenance of homeostasis and the response to the perturbations in the environment. The gene expression profiling in the human hypothalamus-pituitary-adrenal axis was catalogued by generating a large amount of expressed sequence tags (ESTs), followed by bioinformatics analysis (http://www.chgc.sh.cn/ database). Totally, 25,973 sequences of good quality were obtained from 31,130 clones (83.4%) from cDNA libraries of the hypothalamus, pituitary, and adrenal glands. After eliminating 5,347 sequences corresponding to repetitive elements and mtDNA, 20,626 ESTs could be assembled into 9, 175 clusters (3,979, 3,074, and 4,116 clusters in hypothalamus, pituitary, and adrenal glands, respectively) when overlapping ESTs were integrated. Of these clusters, 2,777 (30.3%) corresponded to known genes, 4,165 (44.8%) to dbESTs, and 2,233 (24.3%) to novel ESTs. The gene expression profiles reflected well the functional characteristics of the three levels in the hypothalamus-pituitary-adrenal axis, because most of the 20 genes with highest expression showed statistical difference in terms of tissue distribution, including a group of tissue-specific functional markers. Meanwhile, some findings were made with regard to the physiology of the axis, and 200 full-length cDNAs of novel genes were cloned and sequenced. All of these data may contribute to the understanding of the neuroendocrine regulation of human life.